Literature DB >> 8614292

N-docosahexaenoyl, 3 hydroxytyramine: a dopaminergic compound that penetrates the blood-brain barrier and suppresses appetite.

V E Shashoua1, G W Hesse.   

Abstract

Fatty acids with varying chain lengths (2-22 carbon atoms long) and degrees of unsaturation (0-6 double bonds) were used to synthesize dopaminergic compounds for a study of the carrier mediated transport of dopamine (DA) to the brain. The most active carrier was the all cis C22:6 fatty acid [docosahexaenoic acid, (DHA)]which increased DA uptake through the blood-brain barrier by greater than 7.5 fold. The DHA-DA compound, NMI 8739, depressed the general locomotor activity of mice in a dose dependent manner. It also suppressed the appetite of Balb c mice and Charles River rats by 50% and 95% respectively at a dose of 10 mg/kg. Daily administration of NMI-8739 for a three week period did not induce tolerance. These results demonstrate DHA's potential for the carrier mediated transport of small molecules to the brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614292     DOI: 10.1016/0024-3205(96)00101-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Greasing the wheels of managing overweight and obesity with omega-3 fatty acids.

Authors:  N Golub; D Geba; S A Mousa; G Williams; R C Block
Journal:  Med Hypotheses       Date:  2011-10-06       Impact factor: 1.538

Review 3.  Experimental methods and transport models for drug delivery across the blood-brain barrier.

Authors:  Bingmei M Fu
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

4.  Acetonide Protection of Dopamine for the Synthesis of Highly Pure N-docosahexaenoyldopamine.

Authors:  Zhongqiang Liu; Bi-Huang Hu; Phillip B Messersmith
Journal:  Tetrahedron Lett       Date:  2010-05-01       Impact factor: 2.415

Review 5.  Nanotherapeutic systems for local treatment of brain tumors.

Authors:  Rami Walid Chakroun; Pengcheng Zhang; Ran Lin; Paula Schiapparelli; Alfredo Quinones-Hinojosa; Honggang Cui
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-05-24

Review 6.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

Review 7.  N-Acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids - from fishy endocannabinoids to potential leads.

Authors:  Jocelijn Meijerink; Michiel Balvers; Renger Witkamp
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

8.  Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 To Produce Analgesia in a Rat Model of Chronic Pain.

Authors:  Shannon N Mostyn; Tristan Rawling; Sarasa Mohammadi; Susan Shimmon; Zachary J Frangos; Subhodeep Sarker; Arsalan Yousuf; Irina Vetter; Renae M Ryan; Macdonald J Christie; Robert J Vandenberg
Journal:  J Med Chem       Date:  2019-02-20       Impact factor: 7.446

Review 9.  Blood brain barrier: a challenge for effectual therapy of brain tumors.

Authors:  Arijit Bhowmik; Rajni Khan; Mrinal Kanti Ghosh
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

Review 10.  Bypassing the blood-brian barrier using established skull base reconstruction techniques.

Authors:  Marcel M Miyake; Benjamin S Bleier
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2015-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.